ADARx Pharmaceuticals (ADRX) vs Aurinia Pharmaceuticals (AUPH)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Aurinia Pharmaceuticals is the larger company by market cap ($2.13 billion vs $1.85 billion), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ADRX | AUPH |
|---|---|---|
| Share price | $17.33 | $16.01 |
| Market cap | $1.85B | $2.13B |
| 1-day change | -6.73% | +2.04% |
| YTD return | — | +0.38% |
| 1-year return | — | +36.72% |
| 5-year return | — | -22.17% |
| P/E ratio (TTM) | — | 6.90 |
| Forward P/E | — | 15.01 |
| EPS (TTM) | $-1.16 | $2.32 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $23.21 | $19.25 |
| 52-week low | $17.20 | $10.90 |
| Distance from 52-week high | -25.33% | -16.83% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +11.56% |
| Average volume | 1.42M | 1.01M |
| Shares outstanding | 106.80M | 133.05M |
| Employees | 100 | 128 |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About ADARx Pharmaceuticals
ADRX stock →ADARx Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on developing siRNA therapeutics to treat a broad spectrum of diseases.
Healthcare · Biotechnology · 100 employees
About Aurinia Pharmaceuticals
AUPH stock →Aurinia Pharmaceuticals Inc., a biopharmaceutical company, engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs in the United States and Japan. The company offers LUPKYNIS (voclosporin), an oral therapy for the treatment of adult patients with active lupus nephritis.
Healthcare · Biotechnology · 128 employees
ADRX vs AUPH FAQ
Which is bigger, ADARx Pharmaceuticals or Aurinia Pharmaceuticals?
Aurinia Pharmaceuticals (AUPH) is larger, with a market capitalization of $2.13B compared with $1.85B for ADARx Pharmaceuticals (ADRX).
Are ADARx Pharmaceuticals and Aurinia Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology industry within the Healthcare sector.